logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Lumithera, Inc. Announces Completion Of Diopsys, Inc. Acquisition

Mar 03, 2022•almost 4 years ago

Acquiring Company

LumiThera

Acquired Company

DIOPSYS INC

PoulsboPine BrookHealth CareVideoMedia And EntertainmentContent And PublishingCommerce And ShoppingHardwareConsumer Electronics

Description

LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of its acquisition of Diopsys, Inc., a leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. Diopsys is now a wholly owned subsidiary of LumiThera.

Company Information

Company

LumiThera

Location

19578 10TH AVE NE, SUITE 200

Poulsbo, Washington, United States

About

LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company’s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed